347
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements

ORCID Icon, , , , , , , ORCID Icon, ORCID Icon & show all
Pages 71-83 | Received 08 Sep 2022, Accepted 21 Nov 2022, Published online: 06 Jan 2023

References

  • Aquino MC, Barton K, Tan AM, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2015;43(1):40–46. doi:10.1111/ceo.12360
  • Checo L, Wagner I, Ahuja A, et al. Prospective comparison of different energy parameters of micropulse transscleral laser therapy. Presented at American Glaucoma Society Annual Meeting; 2022; Nashville, TN.
  • Grippo TM, de Crom RM, Giovingo MC, et al. Evidence-based consensus guidelines for micropulse transscleral laser therapy: dosimetry and patient selection. Clin Ophthalmol. 2022;16:1837–1846. doi:10.2147/OPTH.S365647
  • Tan AM, Chockalingam M, Aquino MC, et al. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010;38(3):266–272. doi:10.1111/j.1442-9071.2010.02238.x
  • Radhakrishnan S, Wan J, Tran B, et al. Micropulse cyclophotocoagulation: a multicenter study of efficacy, safety, and factors associated with increased risk of complications. J Glaucoma. 2020;29(12):1126–1131. doi:10.1097/IJG.0000000000001644
  • Magacho L, Lima FE, Ávila MP. Double-session micropulse transscleral laser (CYCLO G6) as a primary surgical procedure for glaucoma. J Glaucoma. 2020;29(3):205–210. doi:10.1097/IJG.0000000000001426
  • Elhefney EM, Mokbel TH, Hagras SM, et al. Micropulsed diode laser cyclophotocoagulation in recurrent pediatric glaucoma. Eur J Ophthalmol. 2020;30(5):1149–1155. doi:10.1177/1120672119858226
  • Abdelrahman AM, El Sayed YM. Micropulse versus continuous wave transscleral cyclophotocoagulation in refractory pediatric glaucoma. J Glaucoma. 2018;27(10):900–905. doi:10.1097/IJG.0000000000001053
  • Kaba Q, Somani S, Tam E, Yuen D. The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma. Ophthalmol Glaucoma. 2020;3(3):181–189. doi:10.1016/j.ogla.2020.02.005
  • Subramaniam K, Price MO, Feng MT, Price FW Jr. Micropulse transscleral cyclophotocoagulation in keratoplasty eyes. Cornea. 2019;38(5):542–545. doi:10.1097/ICO.0000000000001897
  • Patel S, Kakouri A, Chaudhary S, et al. The effect of various media and probe angles on the power output of the cyclo G6 glaucoma laser system. Lasers Med Sci. 2021;36(3):605–609. PMID: 32681220. doi:10.1007/s10103-020-03089-w
  • Iridex. MicroPulse P3 Device. Engineering Specifications. Available from: https://iridex.com/Portals/0/downloads/MicroPulse_P3_Device_Brochure.pdf Accessed 04 January 2023
  • Chamard C, Bachouchi A, Daien V, Villain M. Efficacy, safety and re-treatment benefit of micropulse transscleral cyclophotocoagulation in glaucoma. J Glaucoma. 2021;30:781–788. doi:10.1097/IJG.0000000000001900
  • de Crom RMPC, Slangen CGMM, Kujovic-Aleksov S, et al. Micropulse trans-scleral cyclophotocoagulation in patients with glaucoma: 1- and 2-year treatment outcomes. J Glaucoma. 2020;29(9):794–798. doi:10.1097/IJG.0000000000001552
  • Nguyen AT, Maslin J, Noecker RJ. Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma. Eur J Ophthalmol. 2020;30(4):700–705. doi:10.1177/1120672119839303
  • Varikuti VNV, Shah P, Rai O, et al. Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma. 2019;28(10):901–905. doi:10.1097/IJG.000000000000133
  • Lee JH, Vu V, Lazcano-Gomez G, et al. Clinical outcomes of micropulse transscleral cyclophotocoagulation in patients with a history of keratoplasty. J Ophthalmol. 2020;9(2020):6147248.
  • Preda MA, Karancsi OL, Munteanu M, Stanca HT. Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up. Lasers Med Sci. 2020;35(7):1487–1491. doi:10.1007/s10103-019-02934-x
  • Yelenskiy A, Gillette TB, Arosemena A, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma. 2018;27(10):920–925. doi:10.1097/IJG.0000000000001023
  • Marchand M, Singh H, Agoumi Y. Micropulse trans-scleral laser therapy outcomes for uncontrolled glaucoma: a prospective 18-month study. Can J Ophthalmol. 2021;56(6):371–378. PMID: 33577756. doi:10.1016/j.jcjo.2021.01.015
  • Egorov VV, Samokhvalov NV, Marchenko AN. Clinical evaluation of the results of micropulse laser cyclophotocoagulation in the treatment of refractory glaucoma on the first day after surgery. Mod Technol Ophthalmol. 2020;82–86. doi:10.25276/2312-4911-2020-1-82-86
  • Sarrafpour S, Saleh D, Ayoub S, Radcliffe NM. Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma. 2019;2(3):167–171. doi:10.1016/j.ogla.2019.02.002
  • Souissi S, Baudouin C, Labbé A, Hamard P. Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction. Eur J Ophthalmol. 2021;31(1):112–119. doi:10.1177/1120672119877586
  • Williams AL, Moster MR, Rahmatnejad K, et al. Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma. 2018;27(5):445–449. doi:10.1097/IJG.0000000000000934
  • Grippo TM, Sanchez FG, Stauffer J, Marcellino G. MicroPulse transscleral laser therapy – fluence may explain variability in clinical outcomes: a literature review and analysis. Clin Ophthalmol. 2021;15:2411–2419. doi:10.2147/OPTH.S313875
  • Tong W, Shen TYT, Wong WC, et al. One-year outcomes of micropulse cyclophototherapy for primary open-angle glaucoma. J Glaucoma. 2021;30:911–920. doi:10.1097/IJG.0000000000001925
  • Grippo TM, Brossard Barbosa N, Noecker R, et al. Letter to the editor: one-year outcomes of micropulse cyclophototherapy for primary open-angle glaucoma. J Glaucoma. 2022;31(6):e41–e42. doi:10.1097/IJG.0000000000002040
  • Tong W, Yu Ting Shen T, Wong HC, et al. Response to letter to the editor: one-year outcomes of micropulse cyclophototherapy for primary open-angle glaucoma. J Glaucoma. 2022;31(6):e42. doi:10.1097/IJG.0000000000002041
  • Al Habash A, Al Ahmadi AS. Outcome of micropulse transscleral photocoagulation in different types of glaucoma. Clin Ophthalmol. 2019;13:2353–2360. doi:10.2147/OPTH.S226554
  • Sanchez FG, Lerner F, Sampaolesi J, et al. Efficacy and safety of micropulse transscleral cyclophotocoagulation in glaucoma. Arch Soc Esp Oftalmol. 2018;93(12):573–579. doi:10.1016/j.oftal.2018.08.003
  • Emanuel ME, Grover DS, Fellman RL, et al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma. 2017;26(8):726–729. doi:10.1097/IJG.0000000000000715
  • Jammal AA, Costa DC, Vasconcellos JPC, Costa VP. Prospective evaluation of micropulse transscleral diode cyclophotocoagulation in refractory glaucoma: 1 year results. Arq Bras Oftalmol. 2019;82(5):381–388. doi:10.5935/0004-2749.20190076
  • Logioco C, Perrone LD, Caruso D, et al. Assessment of efficacy and safety of micropulse diode laser treatment in glaucoma: one year follow-up. Arch Soc Esp Oftalmol. 2020;95(7):327–333. doi:10.1016/j.oftal.2020.03.002
  • Tekeli O, Kose HC. Outcomes of micropulse transscleral cyclophotocoagulation in primary open angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma. Eur J Ophthalmol. 2021;31(3):1113–1121. doi:10.1177/1120672120914231
  • Waibel S, Herber R, Pillunat LE, Pillunat KR. One-year follow-up of pars plicata versus pars plana application of transscleral micropulse cyclophotocoagulation. J Glaucoma. 2021;30(4):340–346. doi:10.1097/IJG.0000000000001775
  • Wong KYT, Aquino CM, MAcasaet AM, et al. MP3Plus: a modified micropulse transscleral cyclophototherapy technique for the treatment of refractory glaucoma. J Glaucoma. 2020;29(4):264–270. doi:10.1097/IJG.0000000000001443
  • Zaarour K, Abdelmassih Y, Arej N, et al. Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma. 2019;28(3):270–275. doi:10.1097/IJG.0000000000001174
  • Perez C, Han Y, Rose-Nussbaumer J, Ou Y, Hsia YC. Neurotrophic keratitis after micropulse transscleral diode laser cyclophotocoagulation. Am J Ophthalmology Case Rep. 2019;15:100459. doi:10.1016/j.ajoc.2019.100469
  • Chan P, Lam M, Baig N. Case report – acute corneal subepithelial hydrops during micropulse transscleral cyclophotocoagulation. BMC Ophthalmol. 2020;20:409. doi:10.1186/s12886-020-01669-6
  • Aldaas K, Brasington C, Zhang A, et al. A case of choroidal and vitreous hemorrhage following micropulse transscleral cyclophotocoagulation. J Glaucoma. 2020;29(7):e57–e59. doi:10.1097/IJG.0000000000001529
  • Kiyama Y, Nakashima K, Inour T. A case of primary open angle glaucoma with conjunctival laceration after micropulse transscleral cyclophotocoagulation. J Glaucoma. 2020;29(12):e135–e137. doi:10.1097/IJG.0000000000001658
  • Prager A, Anchala A. Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy. AM J Ophthalmol Case Rep. 2020;18:100659. doi:10.1016/j.ajoc.2020.100659
  • Dhanireddy S, Yin HY, Dosakayala N, et al. Severe inflammation and hyphema after micropulse diode transscleral cyclophotocoagulation. J Glaucoma. 2020;29(6):e50–e52. PMID: 32287149. doi:10.1097/IJG.0000000000001508
  • Garcia GA, Nguyen CV, Yelenskiy A, et al. Micropulse transscleral diode laser cyclophotocoagulation in refractory glaucoma: Short-term efficacy, safety, and impact of surgical history on outcomes. Ophthalmol Glaucoma. 2019;2(6):402–412.